-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Buy on Beta Bionics, Lowers Price Target to $20

Benzinga·04/22/2026 12:30:58
Listen to the news
Stifel analyst Jonathan Block maintains Beta Bionics (NASDAQ:BBNX) with a Buy and lowers the price target from $22 to $20.